20
Jan
2025
Pfizer’s Oxbryta Was Transformational For My Sickle Cell Warriors. Bring it Back
Following Pfizer’s voluntary withdrawal of Oxbryta from the global market, a mother of three daughters battling sickle cell disease shares why patients need it as a therapeutic option. The headline rocked our family to the core. At 5 pm ET, Sept. 25, 2024, the statement read: “Pfizer Voluntarily Withdraws All Lots of Sickle Cell Disease Treatment OXBRYTA® (voxelotor) From Worldwide... Read More